This study investigates the effects of starting an investigational medication before patients with heart failure are discharged from the hospital. Heart failure is a condition where the heart does not pump blood as well as it should, which can lead to fatigue and shortness of breath.
Participants in the study will receive either the investigational medication or a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine. This will help researchers understand the medication's impact on heart failure management.
- Who can participate: Participants should be adults diagnosed with heart failure.
- Study details: Participants will receive either Ivabradine or a placebo. This will help researchers understand the medication's impact on heart failure management.
